Annals of Pediatric Cardiology
About us | Current Issue | Archives | Ahead of Print | Instructions | Submission | Subscribe | Advertise | Contact | Login 


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    Clinical and Pat...
    Activity Assessm...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded1159    
    Comments [Add]    
    Cited by others 41    

Recommend this journal


Table of Contents   
Year : 2013  |  Volume : 6  |  Issue : 1  |  Page : 52-58
Pathology of Takayasu arteritis: A brief review

1 Department of Pathology, (Cardiovascular and Thoracic Division), Seth GS Medical College, Mumbai, Maharashtra, India
2 Department of Pathology, BJ Wadia Children's Hospital, Parel, Mumbai, Maharashtra, India

Click here for correspondence address and email

Date of Web Publication16-Feb-2013


Takayasu arteritis (TA) is a chronic idiopathic and granulomatous vasculitis, manifesting mainly as a panaortitis. Autoimmune cell-mediated immunity is probably responsible for the disease. The inflammation commences from the adventitia and progresses to the intima and leads to, both in adults and children, segmental stenosis, occlusion, dilatation, and/or aneurysm formation. This review focuses briefly on the etiopathogenesis, and describes the pathological and clinical features in adults and children.

Keywords: Large vessel vasculiti, Takayasu arteritis, hypertension

How to cite this article:
Vaideeswar P, Deshpande JR. Pathology of Takayasu arteritis: A brief review. Ann Pediatr Card 2013;6:52-8

How to cite this URL:
Vaideeswar P, Deshpande JR. Pathology of Takayasu arteritis: A brief review. Ann Pediatr Card [serial online] 2013 [cited 2022 Aug 19];6:52-8. Available from:

   Introduction Top

Vasculitides refers to a heterogeneous group of disorders characterized by inflammation of blood vessels resulting in destruction and distortion of the layered components of their walls. The inflammation can result in clinical syndromes ranging from minor self-limiting illness to life-threatening systemic disorder. The categorization of vasculitides hinges on the sizes of the vessels affected, and excludes a direct infective etiology. The diagnosis, however, depends on the site and extent of vascular injury, which in turn is reflected by protean clinical and radiological manifestations, along with altered laboratory parameters. The Chapel Hill Consensus Conference Nomenclature of Vasculitides classification is still widely used and has been recently refined. [1] For children and adolescents, the European League Against Rheumatism (EULAR) and the Pediatric Rheumatology European Society (PRES) endorsed a new classification which particularly addressed the problems of childhood vasculitides, and Takayasu arteritis (TA) is the only large vessel vasculitidis in this age group. [2] The term "large-vessel vasculitis" (LVV) refers to chronic inflammation affecting the elastic arteries, mainly aorta and its major branches. In adults, this group also includes giant cell arteritis (rarely occurring before the age of 50 years) and TA (rarely occurring after the age of 50 years). [3] TA forms the third most frequent vasculitis in childhood in the EULAR/PRES classification of vasculitis. [4] TA is a chronic idiopathic and granulomatous vasculitis, manifesting mainly as a panaortitis. The inflammation commences from the adventitia and progresses to the intima and leads to, both in adults and children, segmental stenosis, occlusion, dilatation, and/or aneurysm formation. This review focuses briefly on the etiopathogenesis, and the pathological features in adults and children.

   Etiopathogenesis Top

TA is known worldwide with an estimated incidence of 1.2-2.6/million per year in the western population and is seen in all races, but the incidence is higher in Southeast Asia, Central and South America, and Africa. [5] It is generally considered a disease of young adults with a peak onset in second and third decades of life and a striking predilection for females. The predisposing and etiological factors of TA have still to be clearly elucidated. An autoimmune basis, influenced by genetic and environmental factors, is strongly suggested; the resulting inflammation is largely a cell-mediated immune response. There is an association between TA and Mycobacterium tuberculosis, but this connection has not been well substantiated. [6] TA also occurs with a variety of autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, sero-negative spondyloarthropathies, inflammatory bowel disease, anterior uveitis, Wegener's granulomatosis, sarcoidosis, amyloidosis, Sweet syndrome, and even some immunodeficiency syndromes. [7] The general understanding is that an unknown stimulus triggers expression of heat shock protein-65 in the aortic tissue, which is also synthesized by other tissues in response to stress. [8] The protein has its homolog in Mycobacteria and many other bacterial species. This protein induces the Major Histocompatibility Class 1 chain-related A on vascular cells. These are recognized by subsets of T lymphocytes, which along with macrophages, produce pro-inflammatory cytokines. This finally results in acute inflammation, necroses, neo-vascularization, smooth muscle migration, intimal proliferation, and giant cell formation. Further, there is recruitment of B lymphocytes with production of anti-endothelial, anti-cardiolipin, and anti-aorta auto-antibodies, which accentuates the inflammatory process. Further, human leukocyte antigen (HLA)-B52 and B39 are associated with TA in Japan, and HLA-DR B1-1301/1302 in Mexico. [8]

   Clinical and Pathological Features of Takayasu Arteritis Top

The disease progression is said to occur in a triphasic pattern. [9] Phase I is the systemic or pre-pulseless period, which is characterized by constitutional symptoms such as low-grade fever, malaise, night sweats, arthralgia, anorexia, and weight loss. Hence, TA should form a differential diagnosis for fever of unknown origin. Phase II is the vasculitic stage where constitutional symptoms are accompanied by features of vascular involvement like tenderness or pain over vessels (angiodynia). The final phase refers to the late, fibrotic, occlusive, quiescent, or "burnt-out" phase, wherein characteristic features of TA (pulseless disease) related to arterial stenosis or occlusion appear. Only a minority of patients show such a temporal progression. The active or acute phases of the disease, which are difficult to diagnose, remit spontaneously in about 3 months or may progress insidiously and relentlessly for months to years into the chronic phase. It is to be noted that inflammatory and fibrotic changes can co-exist.

Diagnosis of TA presents a challenge to the clinician. The disease has non-specific clinical symptoms and has protean manifestations: Ranging from asymptomatic patients with incidental findings such as unequal pulses, to catastrophic presentation such as cerebrovascular accidents. Specific diagnostic criteria have been described by Ishikawa [10] [Table 1] and American College of Rheumatology [11] [Table 2]. Apart from constitutional complaints, nearly all patients with TA sooner or later present with symptoms and signs related to vascular stenosis and/or occlusion. They include hypertension with blood pressure differences in the extremities, pulse deficits, bruit, and upper and/or lower extremity claudications. Neurological, musculoskeletal, and dermatological manifestations are less common. These vascular changes are well delineated through advances in imaging technology. [12]
Table 1: Ishikawa criteria of Takayasu arteritis[15]

Click here to view
Table 2: American college of rheumatology classification criteria of Takayasu arteritis[16]

Click here to view

Around 5% of patients with TA are children and adolescents. Most children are diagnosed between ages 8 and 13 years, and like adults, females outnumber males with a ratio of 3:1. [4],[10] The largest pediatric series of 70 patients was reported by Hong et al; [13] the youngest reported case was 7 months old. [12] Early clinical diagnosis in children is even more challenging, TA should be considered in the differential diagnosis when they present with fever, vomiting, and weight loss; other symptoms include night sweats, back pain, mylagias, and arthralgias. This also simulates acute rheumatic fever, leading to misdiagnosis. [14] In comparison to limb claudication, poor/absent peripheral pulses, or bruits, hypertension is not only the most common mode of presentation, but also very often the only manifestation of TA in children. [14],[15] Hence, modification of the diagnostic criteria for TA has been advocated [Table 3]. [2] One-third of children present with inactive disease, in which clinical features represent vascular sequelae. Presentation with heart failure is also common.
Table 3: EULAR/PRES criteria of Takayasu arteritis[2]

Click here to view

Histopathologic features

In TA, biopsy specimens are seldom available and hence morbid anatomic features are based on autopsy findings [16] or segments excised during bypass surgery. [17] On histology, the lesions can be active, chronic, or healed. Though TA is a panarteritis, the initial site of inflammation is around the vasa vasora and at the medio-adventitial junction. There is edema, and mononuclear cell infiltration (CD4 and CD8 lymphocytes, plasma cells, and macrophages) in the outer thirds of the media and adventitia. Giant cell granulomatous reaction [Figure 1]a and laminar necrosis can also be present. Fragmentation of elastic fibers with "elasticophagia" is prominent. Rapid or more severe inflammation leads to loss of smooth muscle cells, medial weakening, vascular dilatation, and even aneurysm formation. There is reactive fibrosis and increased ground substance in the intima, with overlying layer of thrombus or a band of neo-vascularization at the intimo-medial junction. In the chronic phase [Figure 1]b and 1c, there is patchy mononuclear inflammatory infiltrate with medial scarring and vascularization, while the healed phase [Figure 2] shows only fibrosis in all layers; these two phases are often seen.
Figure 1: (a) Active phase of TA in descending thoracic aorta showing a granulomatous inflammation at the medio-adventitial junction of aorta destroying the structure of an intercostal artery; (b) chronic phase of TA in descending thoracic aorta showing media (M) at the outer third with clusters of mononuclear cells. Note marked fibrosis of the adventitia (A) (Hematoxylin and Eosin, ×250). (c) The cells are lymphocytes, and few plasma cells and histiocytes (Hematoxylin and Eosin, ×250)

Click here to view
Figure 2: Healed phase of TA in descending thoracic aorta: (a) Loose fibrocellular thickening of the intima (I); (b) junctional area between intima (I) and media (M) showing destruction of the elastic lamellae/smooth muscle with replacement fibrosis; (c) similar features are also seen toward the outer third of the media (M) and adventitia (A); (d) fibrotic adventitia (A) showing endarteritis obliterans of a branch (elastic van Gieson, ×250)

Click here to view

Clinically, though aortic arch and renal arteries are often involved, at autopsy it is rare to find disease restricted to aorta and its branches. [16] One or more patterns of disease are noted: (1) Localized aortic segment involvement for a length of 2-7 cm; (2) multiple short segment disease with normal or "skip" areas in between; or (3) diffuse aortic disease with or without a small stretch of normal segments in between. The disease may start at the aortic annulus, but by and large, the infra-renal aorta, inferior mesenteric artery, and iliac arteries are usually not affected. The disease is classified into five types on the basis of the pattern of anatomical involvement: Type I, aortic arch and its branches; Type II, descending thoracic and abdominal aorta; Type III, aortic arch and thoraco-abdominal aorta; Type IV, pulmonary artery in addition to the aforementioned types; and Type V, coronary artery in addition to the other types. [18] Another classification [19] categorizes TA into six types: Type I, aortic arch and its branches; Type IIa, ascending aorta, arch, and its branches; Type IIb, ascending aorta, arch, and its branches, and descending thoracic aorta; Type III, thoracic aorta and abdominal aorta; Type IV, abdominal aorta; and Type V, combination of Type IIb and Type IV. Involvement of coronary arteries is labeled C (+) and involvement of pulmonary arteries is denoted as P (+). All patterns of vascular involvement are observed in all regions, though a distinct pattern is also seen. Japanese patients have a higher incidence of arch involvement (reverse coarctation), while in Southeast Asia, India, and Africa, it is the "middle aortic syndrome" with affection of thoraco-abdominal aorta and renal arteries; the pattern is often diffuse [Figure 3]. In North America, arch vessels and abdominal aorta are more frequently affected.
Figure 3: Scanned images of the ascending aorta, arch, left subclavian artery, descending thoracic aorta (elastic van Gieson), and abdominal aorta (Hematoxylin and Eosin, and elastic van Gieson) in a diffuse pattern of TA. All segments show marked adventitial fibrosis, the major cause of wall thickening. Lymph nodes (arrows) are seen around abdominal aorta

Click here to view

The extent of the aortic disease is apparent on gross examination and it is best seen in children. The aorta feels stiff and rigid on palpation. The most striking feature is the extraordinary degree of adventitial and periadventitial fibrosis [Figure 3], which is in excess to that seen in any other inflammatory disorder of the aorta. This may produce adherence to the neighboring structures. In the early stages of the disease, the thickened adventitia may have a gelatinous appearance. Another feature is the presence of enlarged para-aortic lymph nodes, particularly in the vicinity of renal [Figure 3] and subclavian arteries. The nodes may show caseation necrosis or active hyperplasia. The intimal fibrocellular hyperplasia is seen as plaques, and depending on the amounts of acid mucopolysaccharides and collagen, it appears gelatinous or white, respectively. Gelatinous plaques are characteristically seen in children [Figure 4]a. Sometimes the plaques are large or even circumferential or may even be covered by mural thrombi [Figure 4]b. Sometimes the involvement is seen as diffuse intimal thickening with mild affection of the adventitia [Figure 4]c. Localized disease is also often seen in children and there is always a sharp line of demarcation between normal and diseased segments [Figure 4]d. Superimposed calcification and atherosclerosis accentuates the vascular rigidity [Figure 5]; lesions in children are usually bereft of secondary atherosclerosis.
Figure 4: (a) Abdominal aorta with large, glistening intimal plaques seen around the superior mesenteric (SMA) and left (LRA), right (RRA) renal arteries; (b) single large gelatinous plaque with superimposed thrombosis (t) in descending thoracic aorta (DTA); (c) diffuse intimal thickening with superficial scars and furrows of entire descending aorta; (d) the localized disease affecting the descending thoracic aorta (DTA) is abruptly separated from normal abdominal aorta (AA) by a distinct shelf of intimal thickening

Click here to view
Figure 5: Cobble-stoned intima with atherosclerosis, calcification, and focal ulceration in an excised segment of ectatic descending aorta

Click here to view

When large and/or circumferential, these plaques contribute greatly to luminal stenosis or obliteration. These mainly affect the mid-thoracic level or the region of renal arterial origins [Figure 6]. Depending on the number and sizes of the intimal plaques, the aortic lumen may be irregular or obstructed [Figure 6]. The external diameter of the aorta is, however, the same or is slightly reduced. The exuberant adventitial and intimal fibrosis with consequent aorto-arterial stenosis/occlusion characterizes the pathology of TA, and these features are not seen with other types of LVV. Luminal occlusion results from superimposition of mural thrombus. Medial destruction results in not only vascular ectasia [Figure 5], but also frank aneurysms [Figure 7]a. The aneurysms (saccular or fusiform) occur in 2-6%, but usually co-exist with stenotic lesions; these are also uncommon in children. Aneurysms devoid of stenosis or pseudo-aneurysms are extremely rare, and so are dissections. [20] Dissections may not have acute presentations, are localized, usually affect the abdominal aorta, and at times are not grossly evident [Figure 7]b and c.
Figure 6: Intimal thickening of the abdominal aorta with extensive adventitial/peri-adventitial fibrosis and adherent adipose tissue. Note the presence of narrowing of the aortic lumen in the infra-renal region, and renal arterial ostia (CA, celiac artery; SMA, superior mesenteric artery; RRA, right renal artery; LRA, left renal artery)

Click here to view
Figure 7: (a) Multi-focal aortic disease with skip areas showing a large aneurysm in the abdominal aorta. The wall of the aneurysm when studied histologically also showed the presence of chronic dissection as seen in (b) (Hematoxylin and Eosin, ×100) and (c) (Elastic van Gieson, ×100). Arrow points to the intimal flap. The wall is represented only by thickened intima (I) and adventitia (A)

Click here to view

With branch involvement, the lesions are noted around the ostia. The subclavian (especially the left) and renal arteries are commonly affected. Rarely, all arch arteries can be involved [Figure 8]a. It was initially hypothesized that the disease began at the subclavian arteries, but a latest study shows that TA lesions mostly develop in a symmetric manner in paired vascular territories and are contiguous in the aorta. [21] Pulmonary arterial involvement is found in about 70% of patients [Figure 8]b, [22] is usually mild, and can extend into segmental and sub-segmental branches [Figure 8]c. Therefore, some patients may have features related to pulmonary thromboembolism or hypertension.
Figure 8: (a) There is involvement of all the arch arteries. Luminal obliteration is present in left common carotid artery (LCCA) and left subclavian artery (RBCA, right brachiocephalic artery; RCCA, right common carotid artery; RSA, right subclaivan artery). (b) The involvement of ascending aorta (AA) and pulmonary trunk (PT) is comparable. There is prominent intimal (white arrow) and adventitial (black arrow) thickening; The case also showed inflammation of the segmental branches seen in (c) (Hematoxylin and Eosin, ×250) and (d) (Elastic van Gieson, ×250)

Click here to view

Coronary arterial involvement is usually rare, ostial, and/or proximal. [23] It must be remembered that ascending aorta [Figure 9], pulmonary trunk and its branches, and coronary arteries can be affected in isolation. About 40% of patients develop cardiac abnormalities, manifesting as cardiac failure, seen often in children. The underlying basis for this in most cases is hypertension or ischemia of the hypertrophied myocardium. But not uncommonly, dilated, poorly contractile hearts with features akin to dilated cardiomyopathy occur, and a misdiagnosis of dilated cardiomyopathy is often made by those not familiar with this entity. Rarely, there can be organic aortic valvular involvement or ischemia/infarction related to stenosing or occlusive coronary arterial lesion. At times, there may be myocarditis or aortic valvular incompetence.
Figure 9: A 21-year-old woman, who presented with sudden cardiac death, showed TA manifesting as a band of aortitis affecting the ascending aorta (AA) with narrowing (thin arrow) of the dominant right coronary arterial (RCA) ostium. There is widening of the commissure (thick arrow) between right RCC and left LCC coronary cusps (LV, left ventricle; NCC, non-coronary cusp, LMC, left main coronary ostium)

Click here to view

   Activity Assessment and Therapy Top

Assessing disease activity in TA is challenging as there is frequently a lack of clinical and investigational correlation. New onset or worsening of two or more of the set criteria of TA are said to be indicative of active disease, [24] though angiographic disease progression and histological progression can be seen clinically even during inactive phase of the disease. Similar situation is faced with assessment of laboratory markers such as erythrocyte sedimentation rate (ESR) and several other acute phase reactants. Recent investigations have focused on identification of novel and sensitive biomarkers such as pentraxin-3 [25] and imaging techniques. [11],[12]

In general, there is higher morbidity and mortality in children as compared to adults due to rapid development of hypertension and heart failure. A mortality of 10-30% has been reported on follow-up. [26] With better treatment options now available, the prognosis appears to be improved. The mainstay of treatment is high-dose corticosteroids. [13] Patients who do not respond to steroids or who have a relapse may need to be given methotrexate, azathioprine, or cyclophosphamide. [13] Cyclosporine has been used as an alternative to cyclophosphamide. Tumor necrosis factor inhibition has also been used in relapsing disease or glucocorticoid-resistant cases. There are also interventional or surgical options available. [27],[28] Balloon dilatation alone, stenting if required, and bypass grafting may be done, but the management requires a refined judgment because of the range of patho-anatomic and clinical issues involved.

   Conclusions Top

TA, a large vessel vasculitis in children, remains a fascinating and difficult disease characterized by constitutional features, hypertension, heart failure, and pulse loss. The pathological features vary with the stage of the disease and include granulomatous inflammation, elasophagia, adventitial and medial fibrosis, vessel dilatation, and stenosis or occlusions of the involved arteries. The clinical course of the disease is variable, with the active and quiescent phases, and treatment strategies need individualized management.

   References Top

1.Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013;65:1-11.  Back to cited text no. 1
2.Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PRES endorsed consensus criteria for the classification of childhood vasculitis. Ann Rheum Dis 2006;65:936-41.  Back to cited text no. 2
3.Luqmani R. Large vessel vasculitides: Update for the cardiologist. Curr Opin Cardiol 2012;27:578-84.  Back to cited text no. 3
4.Weiss PF. Pediatric vasculitis. Pediatr Clin N Am 2012;59:407-23.  Back to cited text no. 4
5.Richards BL, March L, Gabriel SE. Epidemiology of large-vessel vasculitides. Best Pract Res Clin Rheumatol 2010;24:871-3.  Back to cited text no. 5
6.Kothari SS. Aetiopathogenesis of Takayasu's arteritis and BCG vaccination: The missing link. Med Hypotheses 1995;45:227-30.  Back to cited text no. 6
7.Al abrawi S, Fouillet-Desjonqueras M, David L, Barral X, Cochat P, Cimaz R. Takayasu arteritis in children. Pediatr Rheumatol Online J 2008;6:17.  Back to cited text no. 7
8.Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z. Pathogenesis of Takayasu's arteritis: A 2011 update. Autoimmun Rev 2011;11:61-7.  Back to cited text no. 8
9.Miller DV, Maleszewski JJ. The pathology of large-vessel vasculitides. Clin Exp Rheumatol 2011;29:S92-8.  Back to cited text no. 9
10.Brunner J, Feldman BM, Tyrrell PN, Kuemmerle-Descher JB, Zimmerhackl LB, Gassner I, et al. Takayasu arteritis in children and adolescents. Rheumatology 2010;49:1806-14.  Back to cited text no. 10
11.Gornik HL, Creager MA. Aortitis. Circulation 2008;117:3039-51.  Back to cited text no. 11
12.Stanley P, Roebuck D, Barboza A. Takayusu's arteritis in children. Tech Vasc Interven Radiol 2003;6:158-68.  Back to cited text no. 12
13.Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, et al. Takayasu arteritis in children: Preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr 2007;150:72-6.  Back to cited text no. 13
14.Muranjan MN, Bavdekar SB, More V, Deshmukh H, Tripathi M, Vaswani R. Study of Takayasu's arteritis in children: Clinical profile and management. J Postgrad Med 2000;46:3-8.  Back to cited text no. 14
[PUBMED]  Medknow Journal  
15.Jain S, Sharma N, Singh S, Bali HK, Kumar L, Sharma BK. Takayasu arteritis in children and young Indians. Int J Cardiol 2000;75:S153-7.  Back to cited text no. 15
16.Kinare SG, Gandhi MA, Deshpande JR. Non-specific aortoarteritis (Pathology and Radiology). Mumbai: Quest Publications; 1998  Back to cited text no. 16
17.Walker M, Gallagher PJ. The surgical pathology of large vessel disease. Diagn Histopathol 2009;16:10-6.  Back to cited text no. 17
18.Gulati A, Bagga A. Large vessel vasculitides. Pediatr Nephrol 2010;25:1037-48.  Back to cited text no. 18
19.Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings in Takayasu arteritis: New classification. Int J Cardiol 1996;54:S155-63.  Back to cited text no. 19
20.Khalife T, Alsac JM, Lambert M, Messas E, Duong Van Huyen JP, Bruneval P, et al. Diagnosis and surgical treatment of a takayasu disease on an abdominal aortic dissection. Ann Vasc Surg 2011;25:556.e1-5.  Back to cited text no. 20
21.Arnaud L, Haroche J, Toledano D, Cacoub P, Mathian A, Costedoat-Chalumeau N, et al. Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arthritis Rheumat 2011;63:1136-40.  Back to cited text no. 21
22.Toledano K, Guralnik L, Lorber A, Ofer A, Yigla M, Rozin A, et al. Pulmonary arteries involvement in Takayasu's arteritis: Two cases and literature review. Semin Arthritis Rheum 2011;41:461-70.  Back to cited text no. 22
23.Lanjewar C, Kerkar P, Vaideeswar P, Pandit S. Isolated bilateral coronary ostial stenosis--an uncommon presentation of aortoarteritis. Int J Cardiol 2007;114:e126-8.  Back to cited text no. 23
24.Kerr GS, Hallahan CW, Giordan J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.  Back to cited text no. 24
25.Dagna L, Salvo F, Tiraboschi M, Bozzolo EP, Franchini S, Doglioni C, et al. Pentraxin-3 as a marker of disease activity in Takayasu's arteritis. Ann Intern Med 2011;155:425-33.  Back to cited text no. 25
26.Kothari SS. Takaysau's arteritis in children - A review. Images Paediatr Cardiol 2001;3:4-23.  Back to cited text no. 26
[PUBMED]  Medknow Journal  
27.Reddy E, Robbs JV. Surgical management of Takayasu's arteritis in children and adolescents. Cardiovasc J Afr 2007;18:393-6.  Back to cited text no. 27
28.Saxena A, Kothari SS, Sharma S, Juneja R, Srivastava S. Percutaneous transluminal angioplasty of the aorta in children with nonspecific aortoarteritis: Acute and follow-up results with special emphasis on left ventricular function. Catheter Cardiovasc Interv 2000;49:419-24.  Back to cited text no. 28

Correspondence Address:
Pradeep Vaideeswar
Department of Pathology (Cardiovascular and Thoracic Division), Seth GS Medical College, Parel, Mumbai - 400 012, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-2069.107235

Rights and Permissions


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8], [Figure 9]

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 Vertebral and carotid artery aneurysms and polyarthritis in a patient with Takayasu arteritis: A case report
Rui-Juan Su, Jun-Meng Zhang, Tao Chen, Yan-Hong Huang
Radiology Case Reports. 2022; 17(3): 832
[Pubmed] | [DOI]
2 Takayasu arteritis with congestive heart failure in 26-year-old male: a case report
Suryono Suryono, Pipiet Wulandari, Dwi Ariyanti, Aditha Satria Maulana, R. Handi Sembodo, Narendra Wahyu Junior, Antonius Dwi Saputra
The Egyptian Heart Journal. 2022; 74(1)
[Pubmed] | [DOI]
3 Imaging of nonatheromatous carotid artery disease
Daniel Montes, Javier M Romero
Clinical and Translational Neuroscience. 2021; 5(1): 2514183X21
[Pubmed] | [DOI]
4 Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis
Rongyi Chen, Lingying Ma, Peng Lv, Jiang Lin, Chaolun Li, Yan Yan, Xuejuan Jin, Xiaomin Dai, Zongfei Ji, Huiyong Chen, Lili Ma, Ying Sun, Lindi Jiang
Arthritis Research & Therapy. 2021; 23(1)
[Pubmed] | [DOI]
5 Unruptured sinus of valsalva aneurysm in a case of large vessel vasculitis: A diagnostic dilemma
Amit A. Deshpande, Amarinder S. Malhi, Debanjan Nandi, Raghav Bansal, Sanjeev Kumar
Journal of Cardiac Surgery. 2021; 36(10): 3874
[Pubmed] | [DOI]
6 Catching Takayasu Early: Diagnosing the “Pulseless” Disease in a Child with Palpable Pulses
A. R. Santosh Rao, Vinay Jahagirdar, Kaanthi Rama, Bibhuti Das
Case Reports in Pediatrics. 2021; 2021: 1
[Pubmed] | [DOI]
7 Bridging Therapy for Acute Stroke as the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature
Yongqiang Dai, Yi Zhong, Banghao Jian, Ping Liu, Kangyu Song, Yu Li, Aimin Wu, Bingjun Zhang
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
8 Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
Xiufang Kong, Ming Xu, Xiaomeng Cui, Lingying Ma, Huiyong Cheng, Jun Hou, Xiaoning Sun, Lili Ma, Lindi Jiang
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
9 Serum C1q concentration is associated with disease activity in Chinese Takayasu arteritis patients: A case-control study
Si Chen, Haixia Luan, Jianxun He, Yan Wang, Xiaoli Zeng, Yongzhe Li, Hui Yuan
Health Science Reports. 2021; 4(2)
[Pubmed] | [DOI]
10 Takayasu arteritis in an adolescent with Crohn’s disease
Lampros Fotis, Afroditi Kourti, Spyridon Prountzos, Efthymia Alexopoulou, Vasiliki Papaevangelou, Smaragdi Fessatou
Rheumatology International. 2021;
[Pubmed] | [DOI]
11 Aortic adventitial thickness as a marker of aortic atherosclerosis, vascular stiffness, and vessel remodeling in systemic lupus erythematosus
Luis P. Roldan, Paola C. Roldan, Wilmer L. Sibbitt, Clifford R. Qualls, Michelle D. Ratliff, Carlos A. Roldan
Clinical Rheumatology. 2021; 40(5): 1843
[Pubmed] | [DOI]
12 Late Diagnosis of Takayasu Arteritis With Unusual Development of Collaterals in Brain and Upper Extremities
Sinsoo Byun, Hyo-Sung Kwak, Chan-Hyuk Lee
The American Journal of the Medical Sciences. 2021; 361(4): 545
[Pubmed] | [DOI]
13 Multiple aneurysms of the subclavian-axillary, abdominal aortoiliac, lower extremity, and coronary arteries in a pediatric patient of Takayasu arteritis
Jian Wang, Changde Li, Yi Zheng, Jianyong Liu, Shi Sheng, Zihui Yuan, Bi Jin, Yiqing Li
Annals of Vascular Surgery. 2021;
[Pubmed] | [DOI]
14 Covered cheatham-platinum stent for treatment of descending thoracic aortic stenosis caused by Takayasu arteritis in two children
Wu Sensen, Guo Julong, Zhang Fan, Tong Zhu, Guo Jianming, Gao Xixiang, Gu Yongquan, Guo Lianrui
Annals of Vascular Surgery. 2021; : 294
[Pubmed] | [DOI]
15 Atypical presentation of Takayasu aortitis and myocarditis contributing to sudden death in a young Canadian first nations adult
Elizabeth O Ferreira, J Kelly MacDonald, Davinder S Jassal, Dennis D Rhee
Cardiovascular Pathology. 2021; 54: 107347
[Pubmed] | [DOI]
16 Clinical characteristics and outcomes of chronic heart failure in adult Takayasu arteritis: A cohort study of 163 patients
Ying Zhang, Peng Fan, Huimin Zhang, Wenjun Ma, Lei Song, Haiying Wu, Jun Cai, Fang Luo, Xianliang Zhou
International Journal of Cardiology. 2021; 325: 103
[Pubmed] | [DOI]
17 Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population
Sifan Wu, Xiufang Kong, Xiaomeng Cui, Huiyong Chen, Lili Ma, Xiaomin Dai, Zongfei Ji, Yan Yan, Qingrong Huang, Ying Sun, Lindi Jiang
Joint Bone Spine. 2021; 88(5): 105186
[Pubmed] | [DOI]
18 Rate and predictors of response to glucocorticoid therapy in patients of takayasu arteritis at a tertiary level hospital of Bangladesh: A longitudinal study
Farzana Shumy, AhmadMursel Anam, MinhajRahim Choudhury, MdAbu Shahin, SyedAtiqul Haq, MdZahid Amin, Sumayia Minhaj
Indian Journal of Rheumatology. 2021; 16(4): 375
[Pubmed] | [DOI]
19 The effect of late diagnosis on survival and risk of vascular complications in Takayasu's arteritis patients
I. E. Borodina, A. A. Popov, L. A. Shardina
Rheumatology Science and Practice. 2021; 59(6): 720
[Pubmed] | [DOI]
20 New Information for the Diagnosis and Treatment of Systemic Vasculitis
Noboru Kitamura, Masami Takei
Journal of Nihon University Medical Association. 2020; 79(2): 107
[Pubmed] | [DOI]
21 Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis
Lili Pan, Juan Du, Jiayi Liu, Hua Liao, Xiaoli Liu, Xi Guo, Jing Liang, Hongya Han, Lixia Yang, Yujie Zhou
Clinical Rheumatology. 2020; 39(8): 2369
[Pubmed] | [DOI]
22 Patterns of clinical presentation in Takayasu's arteritis
Kaitlin A. Quinn, K. Bates Gribbons, Simon Carette, David Cuthbertson, Nader A. Khalidi, Curry L. Koening, Carol A. Langford, Carol A. McAlear, Paul A. Monach, Larry W. Moreland, Christian Pagnoux, Philip Seo, Antoine G. Sreih, Kenneth J. Warrington, Steven R. Ytterberg, Elaine Novakovich, Peter A. Merkel, Peter C. Grayson
Seminars in Arthritis and Rheumatism. 2020; 50(4): 576
[Pubmed] | [DOI]
23 Use of Contrast-Enhanced Ultrasound for Detecting the Disease Activity of the Carotid Artery in Takayasu Arteritis
Li, MD Chaolun, Ma, MD Lingying, Huang, MD Linjin, Han, MD Hong, Jiang, MD Lingdi, Wang, MD Wenping
[Pubmed] | [DOI]
24 Takayasu arteritis in a patient presenting with stroke and improvement of hemiparesis following vascular bypass surgery: A case report
Zoltan Galajda, Felician Stancioiu, Demetrios A. Spandidos, George Lazopoulos, Mihai Cucu, Eugen Qendro, Marius Floroiu, Stelios Kteniadakis
World Academy of Sciences Journal. 2020;
[Pubmed] | [DOI]
25 Weight Loss, Fever, Cough, and Night Sweats in an 11-year-old Girl
Donovan P. Berens, Hanna S. Huh, Lynnette J. Mazur
Pediatrics in Review. 2020; 41(Supplement): S67
[Pubmed] | [DOI]
26 Takayusu Arteritis on the background of congenital vascular anomaly?
I. E. Borodina, I. V. Sablin, A. A. Popov, A. N. Ageev
Kardiologiia. 2020; 60(6): 13
[Pubmed] | [DOI]
27 Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis
J P Santos, R Artigiani Neto, C L P Mangueira, R Z Filippi, P S Gutierrez, J Westra, E Brouwer, A W S de Souza
Clinical and Experimental Immunology. 2020; 202(3): 384
[Pubmed] | [DOI]
28 Comparison of Clinical, Angiographic Features and Outcome in Takayasu's Arteritis and Behçet's Disease With Arterial Involvement
Su Jin Choi, Hyun Jung Koo, Dong Hyun Yang, Joon-Won Kang, Ji Seon Oh, Seokchan Hong, Yong-Gil Kim, Bin Yoo, Chang-Keun Lee
Journal of Rheumatic Diseases. 2020; 27(2): 100
[Pubmed] | [DOI]
29 Novel Biomarkers for the Precisive Diagnosis and Activity Classification of Takayasu Arteritis
Xiao Cui, Fang Qin, Lei Song, Tian Wang, Bin Geng, Weili Zhang, Ling Jin, Wenjie Wang, Shuangyue Li, Xinping Tian, Huimin Zhang, Jun Cai
Circulation: Genomic and Precision Medicine. 2019; 12(1)
[Pubmed] | [DOI]
30 Pathogenesis of large vessel vasculitis: Implications for disease classification and future therapies
Amer Harky, Matthew Fok, Damian Balmforth, Mohamad Bashir
Vascular Medicine. 2019; 24(1): 79
[Pubmed] | [DOI]
31 Assessment of Endothelial Function in Patients with Takayasu Arteritis by Measuring Flow-Mediated Vasodilation and Correlating it with Plasma Levels of Reactive Nitrogen Intermediates
Nagendra Boopathy Senguttuvan, Senguttuvan Jain, Ravindran Rajendran, Veena Dhawan, Ajay Bahl, Subhash C. Varma
Journal of Evolution of Medical and Dental Sciences. 2019; 8(32): 2563
[Pubmed] | [DOI]
32 Aortitis
Kathryn.J Griffin
Diagnostic Histopathology. 2018; 24(11): 475
[Pubmed] | [DOI]
33 Long-Term Outcomes of Pediatric Renovascular Hypertension
Hyun Chung, Jae Hwan Lee, Eujin Park, Hyesun Hyun, Yo Han Ahn, Hwan Jun Jae, Gi Beom Kim, Il Soo Ha, Hae Il Cheong, Hee Gyung Kang
Kidney and Blood Pressure Research. 2017; 42(3): 617
[Pubmed] | [DOI]
34 Takayasu Arteritis in an Older Man with Pulmonary Embolism
Tomonori Tadokoro,Sho Shimamoto,Tadanobu Matsuzaki,Yasutaka Iwanaga,Yasuhisa Tamura
General Medicine. 2015; 16(1): 37
[Pubmed] | [DOI]
35 A Case of Aortitis with Systemic Lupus Erythematosus
Su-Young Jung,Hye-Sun Park,Jong Hyun Jhee,Choong-Kun Lee,Ji-Yeon Lee,Ji-Eun Park,Seung-Hee Han,Yong-Beom Park,Soo-Kon Lee,Sang-Won Lee
Journal of Rheumatic Diseases. 2015; 22(3): 205
[Pubmed] | [DOI]
Gerald Liew,Adnan Tufail,Victoria F. Cosatto,Ava G. Tan,Javier Zarranz-Ventura,Dawn A. Sim,Pearse A. Kean,Catherine A. Egan,Paul Mitchell,Mark C. Westcott,Richard W. J. Lee,Carlos E. Pavesio
Retina. 2015; 35(4): 803
[Pubmed] | [DOI]
37 Childhood-onset Takayasu arteritis: an update
Ashish J. Mathew,Ruchika Goel,Sathish Kumar,Debashish Danda
International Journal of Rheumatic Diseases. 2015; : n/a
[Pubmed] | [DOI]
38 Comparison of clinical characteristics in patients with Takayasu arteritis with and without concomitant tuberculosis
A. Young Lim,Ga Yeon Lee,Shin Yi Jang,Hye Bin Gwag,Seung Hyuk Choi,Eun-Seok Jeon,Hoon-Suk Cha,Kiick Sung,Young-Wook Kim,Sung Mok Kim,Yeon Hyeon Choe,Won-Jung Koh,Duk-Kyung Kim
Heart and Vessels. 2015;
[Pubmed] | [DOI]
39 Recent advances in the medical management of Takayasu arteritis
Alison Clifford,Gary S. Hoffman
Current Opinion in Rheumatology. 2014; 26(1): 7
[Pubmed] | [DOI]
40 Bóle brzucha jako rzadki objaw choroby Takayasu u 14-letniego chlopca – opis przypadku i przeglad pismiennictwa
Agnieszka Szymlak,Katarzyna Bak-Drabik,Agata Chobot,Jolanta Porebska,Agata Mikolajczak,Jolanta Myga-Porosilo,Katarzyna Ziora,Joanna Oswiecimska
Pediatria Polska. 2014;
[Pubmed] | [DOI]
41 result 2 Document Riesenzellarteriitis und Takayasu Arteriitis: Klinische Aspekte, Diagnostik und Therapie | [Giant cell arteritis and takayasu arteritis: Clinical aspects, diagnostics and therapy]
Wagner, A.D., Schmidt, W.A.
Aktuelle Rheumatologie. 2013;